Deutsche Bank analyst Neena Bitritto-Garg initiates coverage on Neumora Therapeutics (NASDAQ:NMRA) with a Hold rating and announces Price Target of $13.
Deutsche Bank Initiates Coverage On Neumora Therapeutics With Hold Rating, Announces Price Target of $13
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.